Tag: atezolizumab

March 7, 2019 Off

Syndax expects milestone-rich time ahead

By Dino Mustafić

Syndax Pharmaceutical expects the coming months to be a very exciting, milestone-rich, said Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, in a press release Thursday, reporting financial results, fourth quarter ended December 31, 2018.